1 Recent evidence has indicated that the mitogen platelet-derived growth factor (PDGF) can act acutely to regulate arterial tone. In this study we demonstrate that the BB isoform of PDGF (PDGF-BB) can cause endothelium-independent relaxation of rabbit isolated mesenteric arteries. 2 In endothelium-denuded arteries, PDGF-BB (40 pM ± 8.0 nM) caused concentration-dependent relaxation of noradrenaline-induced tone. The relaxation to PDGF-BB was abolished by a cyclooxygenase inhibitor, indomethacin (10 mM) and by the PDGF receptor-associated tyrosine kinase inhibitor, tyrphostin AG1295 (50 mM), but not by N G -monomethyl-L-arginine (L-NMMA, 200 mM), an inhibitor of nitric oxide (NO) synthase. 3 PDGF-BB (4.0 nM) signi®cantly increased the release of prostacyclin (PGI 2 ) in endotheliumdenuded arteries. Exogenously applied iloprost (1 mM), a stable analogue of PGI 2 , relaxed the endothelium-denuded artery. PDGF-BB (4.0 nM) signi®cantly increased the cyclic AMP content. 4 In the absence of Ca 2+ , PDGF-BB (4.0 nM) failed to relax the artery, and the release of PGI 2 was almost completely suppressed. In addition, the release of PGI 2 by PDGF-BB (4.0 nM) was signi®cantly reduced in the presence of endothelium. The eect of endothelium was eliminated by L-NMMA (200 mM) and PGI 2 release increased. 5 These data indicate that in rabbit mesenteric arteries, PDGF-BB can evoke endotheliumindependent relaxation by stimulating the synthesis of PGI 2 . The PDGF-BB-induced prostaglandin synthesis is dependent on both Ca 2+ and tyrosine phosphorylation of the PDGF receptor, and is attenuated by endothelium-derived NO.
Introduction
Platelet-derived growth factor (PDGF) is a potent mitogen which plays a primary role in the vascular response to injury and the development of atherosclerosis by stimulating cell proliferation and migration (Ross, 1993; Ross et al., 1986) . PDGF is a dimer protein composed of two homologous polypeptide chains (A and B), and two receptors for PDGF (a and b) bind these two PDGF chains with dierent anities (Claesson-Welsh, 1994) . The a-receptor binds both PDGF-A and -B chains with similar anity, whereas the b-receptor binds only the PDGF-B chain. Binding of PDGF chains to the speci®c receptors can induce the receptor dimerization and subsequent autophosphorylation at sites of tyrosine residues, which appears to be an important process in the biological actions of PDGF (Claesson-Welsh, 1994) . There is accumulating evidence indicating that, in addition to mitogenic actions, PDGF has acute eects on blood vessels to change their contractility. For example, it has been shown that PDGF causes a contraction in smooth muscle of the rat aorta (Berk et al., 1986; Cunningham et al., 1992) , rabbit ear artery (Hughes, 1995) , and rabbit aorta (deBlois et al., 1992) . It has been demonstrated that the contractile eect of PDGF is associated with the activation of receptor tyrosine kinase (Hughes, 1995; Sauro & Thomas, 1993) and the increase in the cytosolic Ca 2+ concentration in smooth muscle (Berk et al., 1986; Hughes, 1995) . In contrast, it has also been reported that PDGF causes relaxation of smooth muscle in the rat aorta and mesenteric superior and resistance artery which is endothelium-dependent (Cunningham et al., 1992; Ikeda et al., 1997; Takase et al., 1999) . The endotheliumdependent relaxation has been shown to be mediated by endothelial-derived nitric oxide (NO; Ikeda et al., 1997) . Despite the accumulating evidence, the precise mechanisms of the acute eects of PDGF on blood vessels are not fully understood. In the present study, we examined the mechanism of acute eects of PDGF on contractile responses in isolated rabbit superior mesenteric artery and show that PDGF can induce an endotheliumindependent vascular relaxation via the release of vasodilator prostaglandin.
Methods

Tissue preparation
Male Japanese White rabbits (2 ± 3 kg) were euthanized by stunning and exsanguination. The main branches of the superior mesenteric arteries (approximately 0.4 mm in internal diameter) were isolated. After removal of fat and adventitia, each artery was cut into rings approximately 2 mm wide for the measurement of muscle tension. The endothelium was removed by rubbing the intimal surface with the¯at face of a pair of forceps. Removal of the endothelium was con®rmed by the lack of relaxation induced by carbamylcholine chloride (carbachol, 1 mM). Animal care and treatment were conducted in conformity with institutional guidelines of The University of Tokyo.
Measurement of muscle tension
The arterial rings were placed in normal physiological salt solution (PSS), which contained (mM): NaCl 136.9, KCl 5.4, CaCl 2 1.5, MgCl 2 1.0, NaHCO 3 23.8, glucose 5.5, and ethylenediaminetetraacetic acid (EDTA) 1 mM. The Ca
2+
-free solution was prepared by excluding CaCl 2 and adding O, O'-bis (2-aminoethyl) ethyleneglycol-N,N,N',N'-tetra-acetic acid (EGTA, 2 mM). The high-K + (65.4 mM) solution was prepared by replacing NaCl with equimolar KCl. These solutions were saturated with a 95% O 2 ± 5% CO 2 mixture at 378C and pH 7.4. Muscle tension was recorded isometrically with a force-displacement transducer (Orientec, Japan). Each muscle ring was mounted in a 2-ml organ bath under a resting tension of 10 mN. After 30 mins equilibration, each ring was repeatedly exposed to high-K + solution until the responses became stable (60 ± 90 min). Concentration-response curves were obtained by the cumulative application of PDGF isoforms (AA and BB) to arteries pre-contracted with noradrenaline (10 mM). The magnitude of the contraction to noradrenaline was 90.3+1.0% (n=14) of the maximum contraction induced by 100 mM noradrenaline (Yamawaki et al., 2000) . In some experiments, a maximally eective concentration of endothelin-1 (100 nM; Iwasaki et al., 1999) was used to induce pre-constriction. Data are shown as per cent relaxations of the steady-state preconstriction.
Measurement of 6-keto-prostaglandin F 1a (PGF 1a )
Bolus doses of PDGF-BB (0.4, 2.0 or 4.0 nM) were applied to tissues pre-contracted with noradrenaline (10 mM) and tension continuously monitored. When the PDGF-induced relaxation reached a steady state (approximately 15 min after the PDGF-treatment), the incubation solution (50 ml) was collected. In the control experiments, vehicle (distilled water) was applied instead of PDGF-BB. The concentration of 6-keto-PGF 1a (a stable product of prostacyclin, PGl 2 ) in the incubation solution was measured with enzyme immunoassay (EIA) kits according to the manufacturer's protocol (RPN 221, Amersham Life Sciences, U.S.A.). The measurable range of 6-keto-PGF 1a by this method was 0.5 ± 64 pg. The concentration of prostaglandin is expressed as pg mg 71 tissue wet weight.
Measurement of cyclic AMP
Endothelium-denuded arterial rings were equilibrated in PSS aerated with a 95% O 2 ± 5% CO 2 mixture at 378C for 45 min without resting tension before the start of experiments. After pretreatment with noradrenaline (10 mM) for 10 min, arterial rings were incubated with PDGF-BB (4.0 nM) for 20 min in the presence of phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX, 500 mM). In the control experiments, vehicle (distilled water) was added instead of PDGF-BB. After the incubation, the arterial preparations were quickly frozen with liquid nitrogen and homogenized in ice-cold 6% trichloroacetic acid (TCA) with a Polytron homogenizer. After centrifugation at 15006g for 15 min, TCA in the supernatant was removed by washing with water-saturated ether, and cyclic AMP was measured with EIA kits according to the manufacturer's protocol (RPN 225, Amersham Life Sciences, U.S.A.). The measurable range of cyclic AMP by this method was 12.5 ± 3200 fmol. The protein concentration of each preparation was determined by the method described by Bradford (1976) , and the content of cyclic AMP was expressed as pmol mg 71 protein.
Chemicals
The chemicals used were as follows: indomethacin, IBMX (Sigma, U.S.A.), EDTA and EGTA (Dojindo Laboratories, Japan), NS-398 (Cayman Chemical, U.S.A.), 6-keto-PGF 1a EIA system, cyclic AMP EIA system (Amersham Life
, caeine, carbachol (Wako Pure Chemical, Japan), recombinant human PDGF-AA, PDGF-BB (Austral Biologicals, U.S.A.), endothelin-1 (Peptide Institute, Japan), tyrphostin AG1295 (Calbiochem, U.S.A.), and iloprost (generous gifts from Eisai Co., Japan).
Statistical analysis
Results are expressed as mean+s.e.mean. Statistical evaluation of the data was performed by unpaired Student's t-test for comparisons between two groups and by one-way analysis of variance (ANOVA) followed by Dunnett's test for comparisons between more than two groups. A value of P50.05 was taken as signi®cant. All pD 2 values were calculated as the 7log 10 EC 50 (i.e. that concentration at which the half maximal eect occurred) by sigmoidal curve ®tting.
Results
Effects of PDGF on rabbit mesenteric arterial smooth muscle
In endothelium-denuded segments of rabbit mesenteric artery, cumulative additions of PDGF-BB (2.0 pM ± 8.0 nM) did not change the resting tension (n=5). However in endothelium-denuded tissues pre-contracted with noradrenaline (10 mM), cumulative additions of PDGF-BB (40 pM ± 8.0 nM) induced a concentration-dependent relaxation (Figure 1A ,B) with a pD 2 value of 9.08+0.13 (n=11). The maximal relaxation caused by 8.0 nM PDGF-BB was 87.0+3.4% (n=11). The 4.0 nM PDGF-BB-induced relaxation started after a delay of 2.8+0.4 min and reached a peak at 15.9+0.5 min (n=24).
In the endothelium-denuded arteries, AA isoform of PDGF (PDGF-AA, 2.0 pM ± 8.0 nM) did not change the resting tension (n=6). In contrast, the cumulative addition of PDGF-AA (40 pM ± 8.0 nM) induced a concentration-dependent relaxation of noradrenaline-induced tone ( Figure 1B ) with a pD 2 value of 9.08+0.38 (n=10). The maximal relaxation caused by 4.0 nM PDGF-AA (56.8+9.0%) was signi®cantly less than that of PDGF-BB (P50.01).
Effects of inhibitors on the PDGF-induced relaxation
Pretreatment of endothelium-denuded rabbit mesenteric arteries with a NO synthase inhibitor, L-NMMA (200 mM, added 30 min before the addition of noradrenaline), had no eect on the PDGF-BB (40 pM ± 4.0 nM)-induced relaxation of noradrenaline-induced pre-constriction (Figure 2, n=6) . In contrast, indomethacin (10 mM, 30 min), a non-selective inhibitor of cyclo-oxygenase (COX), completely abolished the PDGF-BB-induced relaxation (Figure 2, n=6) . On the other hand, NS-398 (1 mM, 30 min), a speci®c inhibitor of the inducible isoform of COX (COX-2), had no eects on the PDGF-BB-induced relaxation (Figure 2, n=10) . In addition, tyrphostin AG1295 (50 mM, 15 min), a speci®c inhibitor of PDGF receptor-associated tyrosine kinase, almost completely abolished the PDGF-BB-induced relaxation (Figure 2, n=7) .
None of these inhibitors altered the amplitude of the contraction to noradrenaline (10 mM; n=6 ± 10).
Release of prostaglandin from the arterial tissue
In control endothelium-denuded rabbit mesenteric arteries, the amount of PGI 2 released into the incubation solution was 8.5+2.5 pg mg 71 wet weight (n=6). In the arteries stimulated with PDGF-BB (0.4, 2.0, or 4.0 nM), the release of PGI 2 increased in a concentration-dependent manner ( Figure  3 , n=6 ± 7). Treatment with indomethacin (10 mM, added 30 min before the addition of noradrenaline) completely suppressed the 4.0 nM PDGF-BB-induced PGI 2 release (Figure 3, n=6, P50 .01).
Effects of PDGF on cyclic AMP content in smooth muscle
In the absence of PDGF-BB, the content of cyclic AMP in the endothelium-denuded rabbit mesenteric arteries was 46.1+8.7 pmol mg 71 protein (n=11). In the arteries treated with PDGF-BB (4.0 nM) for 20 min, the content of cyclic AMP increased signi®cantly to 92.3+20.0 pmol mg 71 protein (n=11, P50.05).
Role of Ca 2+ on the PDGF-induced relaxation
It has been shown that endothelin-1 but not noradrenaline causes a considerable contraction of vascular smooth muscle, even in the absence of external Ca 2+ (Hori et al., 1992) . Therefore, we used endothelin-1 as a vasoconstrictor to examine the role of Ca 2+ on the PDGF-induced relaxation. In normal PSS, maximally eective concentration of endothelin-1 (100 nM) caused a transient contraction followed by a sustained contraction in the endothelium-denuded rabbit mesenteric artery ( Figure 4A ). The addition of PDGF-BB (4.0 nM) inhibited the endothelin-1-induced sustained contraction by 77.0+3.7% (n=10). This value was not signi®cantly dierent from the eect of 4.0 nM PDGF-BB on noradrenaline-induced tone (63.4+3.8%, n=39). In Ca 2+ -free PSS with EGTA (2 mM), the addition of caeine -free PSS, the addition of endothelin-1 (100 nM) caused a sustained contraction which was not altered by PDGF-BB (4.0 nM; n=10). In contrast, iloprost (1 mM), a stable analogue of PGI 2 , inhibited the contraction by 61.6+3.6% (n=5). In the absence of Ca 2+ , the release of PGI 2 by PDGF-BB (4.0 nM) was almost completely suppressed (1.5+0.9 pg mg 71 wet weight, n=4, P50.01).
Effects of endothelium on the PDGF-induced relaxation and prostaglandin release
In the endothelium-intact rabbit mesenteric arteries, the cumulative addition of PDGF-BB (40 pM ± 4.0 nM) also caused a concentration-dependent relaxation of the 10 mM noradrenaline-induced contraction ( Figure 5A, n=10) . However, the relaxation due to 2.0 or 4.0 nM PDGF-BB was signi®cantly smaller in the endothelium-intact arteries (P50.05).
In the absence of PDGF-BB, the amount of PGI 2 released from the endothelium-intact rabbit mesenteric arteries was 3.0+0.9 pg mg 71 wet weight (n=6, Figure 5B ). This value was similar to that in the control endothelium-denuded arteries (3.4+1.6 pg mg 71 wet weight, n=5, Figure 5B ). In endothelium-intact arteries stimulated with PDGF-BB (4.0 nM), release of PGI 2 increased signi®cantly to 11.9+1.4 pg mg 71 wet weight ( Figure 5B , n=6, P50.01 from control endothelium-intact arteries). However, this value was signi®cantly smaller than in the endotheliumdenuded arteries stimulated with 4.0 nM PDGF-BB (20.1+2.4 pg mg
71
, wet weight, n=6, P50.05, Figure 5B ). In the endothelium-intact arteries pretreated with L-NMMA (200 mM, added 30 min before the addition of noradrenaline), release of PGI 2 by PDGF-BB (4.0 nM) increased to the level similar to that in the endothelium-denuded arteries (19.6+2.6 pg mg 71 wet weight, n=6, Figure 5B ).
Discussion
In the present study, we have shown that PDGF (-AA and -BB) causes relaxation of the endothelium-denuded rabbit mesenteric artery pre-contracted with noradrenaline. This is the ®rst report of PDGF causing relaxation of vascular smooth muscle in an endothelium-independent manner. It was also noted that PDGF (-AA and -BB) (2.0 pM ± 8.0 nM) does not cause a contraction in the rabbit mesenteric artery.
In agreement with the present results, Takase et al. (1999) have reported that all isoforms of PDGF (PDGF-AA, -BB, and -AB) (0.1 ± 10 nM) had no contractile eect in rat mesenteric resistance artery. In other studies, however, it has been reported that isoforms of PDGF cause a contraction in the rat aorta (Berk et al., 1986; Cunningham et al., 1992) , rabbit ear artery (Hughes, 1995) , and rabbit aorta (deBlois et al., 1992) . The EC 50 value for rabbit aorta was around 1 nM whereas the values for rat aorta and rabbit ear artery were much lower (around 30 pM). These results suggest the presence of tissue dierences in the sensitivity to the contractile eect of PDGF. It has also been demonstrated that isoforms of PDGF cause an endothelium-dependent NO-mediated relaxation in rat aorta (Cunningham et al., 1992; Ikeda et al., 1997) and rat superior (Ikeda et al., 1997) and resistance mesenteric artery (Takase et al., 1999) . In the rat aorta that EC 50 value for the endothelium-dependent relaxant eect of PDGF (around 100 pM) was higher than that for the contractile eect (around 30 pM). In the present experiments, we Figure 3 Concentration-dependent eects of PDGF-BB on the release of PGI 2 (measured as 6-keto-PGF 1a ) in the endotheliumdenuded rabbit mesenteric arteries. PDGF-BB (0.4, 2.0 or 4.0 nM) was applied to the arteries pre-contracted with noradrenaline (10 mM). When the PDGF-induced relaxation reached a steady-state (approximately 15 min after the PDGF-treatment), the incubation solution (50 ml) was collected. PGI 2 in the incubation solution was measured by enzyme immunoassay (EIA), and the amounts are expressed as pg mg 71 tissue wet weight. Inhibitory eect of indomethacin (10 mM, added 30 min before the addition of noradrenaline) on the PDGF-BB (4.0 nM)-induced PGI 2 release was also examined. Results are expressed as mean+s.e.mean of 6 ± 7 experiments. **Signi®cantly dierent from the PGI 2 release in the absence of PDGF-BB with P50.01. examined the eects of wide concentration range (2.0 pM ± 4.0 nM) of PDGF (-AA and -BB) and found that PDGF did not relax the endothelium-intact artery in the presence of indomethacin (n=4). This result suggests that PDGF cannot cause an endothelium-dependent NO-mediated relaxation in the rabbit mesenteric artery.
As isoforms of PDGF other than PDGF-BB had a small, if any, eect on endothelium-dependent relaxation in the rat aorta (Cunningham et al., 1992; Ikeda et al., 1997) and rat resistance mesenteric artery (Takase et al., 1999) , presence of the b-receptor in the endothelium was predicted. In the present study, both PDGF-AA and PDGF-BB caused a relaxation in the endothelium-denuded rabbit mesenteric artery, although the relaxant eect of PDGF-BB was larger than that of PDGF-AA. Although these observations suggest that both the PDGF a-and b-receptors may be responsible for the endothelium-independent relaxant eects, molecular biological experiments are necessary to identify the exact receptor subtypes.
It is well documented that the tyrosine phosphorylation of the PDGF receptor is a prerequisite for exerting the biological action of PDGF (Claesson-Welsh, 1994) and that contractile eect of PDGF is associated with the tyrosine kinase activation (Hughes, 1995; Sauro & Thomas, 1993) . The present results indicate that tyrphostin AG1295, a highly selective inhibitor of PDGF receptor tyrosine kinase (Kovalenko et al., 1994; Levitzki & Gazit, 1995) , almost completely suppressed the PDGF-BB-induced endotheliumindependent relaxation. This result suggests that endothelium-independent relaxation caused by PDGF is associated with the tyrosine phosphorylation of the PDGF receptor.
The PDGF-BB-induced relaxation was not aected by pretreatment with an NO synthase inhibitor, L-NMMA, suggesting that NO is not involved in the PDGF-induced relaxation. However, treatment with indomethacin, an inhibitor of COX, completely abolished the PDGF-BBinduced relaxation. In addition, PDGF-BB signi®cantly increased the release of PGI 2 from the arteries. Furthermore, exogenously applied iloprost, a stable analogue of PGI 2 , to the endothelium-denuded rabbit mesenteric artery inhibited the noradrenaline-induced contraction (the maximal relaxation elicited by 1 mM iloprost was 75.0+7.6%, n=4). These results suggest that PDGF-BB-induced relaxation is due to the release of PGI 2 . It is well known that the vasodilator prostaglandins, including PGI 2 , activate adenylate cyclase to increase the cyclic AMP content in smooth muscle (Smith, 1986) . We also showed that PDGF signi®cantly increased the amount of cyclic AMP in the endothelium-denuded arteries. It has been reported that forskolin, an activator of adenylate cyclase, inhibited the noradrenaline-induced contraction in the rabbit mesenteric artery (Ito et al., 1993; Khan et al., 1993) . Thus, the present results strongly suggest that PDGF-BB-induced relaxation is due to the release of PGI 2 and the subsequent stimulation of cyclic AMP synthesis.
COX is the enzyme that converts arachidonic acid to PGH 2 , which can be further metabolized to prostanoids including PGI 2 , PGE 2 , and thromboxane A 2 (Otto & Smith, 1995) . It is well recognized that COX exists in at least two distinct isoforms. COX-1 is constitutively expressed in many cell types, including vascular smooth muscle cells (Pritchard et al., 1994; Vinals et al., 1997) . In contrast, COX-2 is induced by proin¯ammatory or mitogenic stimuli. It has recently been reported that PDGF causes an induction of COX-2 mRNA followed by the synthesis of COX-2 protein and prostanoid in cultured aortic smooth muscle cells (Rimarachin et al., 1994) . These authors have also suggested that the induction of COX-2 mRNA by PDGF requires a lag time in which the induction peaks at 45 ± 90 min. In contrast, the present results showed that PDGF-BB caused a relaxation that peaked at approximately 15 min and that NS-398, a selective inhibitor of COX-2 (Gierse et al., 1995) , failed to inhibit the PDGF-induced relaxation, although indomethacin, a nonselective inhibitor of COX, completely inhibited the relaxation suggesting that the relaxant eect of PDGF-BB is mediated by COX-1.
In the present study, PDGF-induced relaxation was completely suppressed in the absence of Ca 2+ and the release of PGI 2 by PDGF-BB was almost completely suppressed in the absence of Ca
2+
. These results suggest that PDGF-BB cannot stimulate the synthesis of prostaglandin in the absence Figure 5 (A) Concentration-relaxation relationship for PDGF-BB on the noradrenaline-induced sustained contraction in the endothelium-denuded or endothelium-intact rabbit mesenteric arteries. PDGF-BB (40 pM ± 4.0 nM) was cumulatively added after the contraction induced by noradrenaline (10 mM) had reached a steady state. 100% represents the steady-state pre-constriction. Results are expressed as mean+s.e.mean of 8 ± 10 experiments. *Signi®cantly dierent with P50.05. (B) Release of PGI 2 from the endotheliumdenuded and endothelium-intact rabbit mesenteric arteries stimulated without or with PDGF-BB. PDGF-BB (4.0 nM) was applied to the muscle pre-contracted with noradrenaline (10 mM). When the PDGFinduced relaxation reached a steady state (approximately 15 min after the PDGF-treatment), the incubation solution (50 ml) was collected. PGI 2 in the incubation solution was measured by enzyme immunoassay (EIA), and the amounts are expressed as pg mg of Ca 2+ and thus fails to cause a relaxation of smooth muscle. This proposal is supported by the observation that exogenously applied iloprost, a PGI 2 analogue, which has been shown to inhibit smooth muscle contraction not only by decreasing the cytosolic Ca 2+ levels but also by decreasing the Ca 2+ -sensitivity of contractile elements (Ozaki et al., 1996) , caused a relaxation of smooth muscle even in the absence of Ca 2+ . We further examined the in¯uence of endothelium on the PDGF-BB-induced relaxation and found that the presence of endothelium signi®cantly attenuated the relaxant eect of PDGF. Consistent with this result, release of PGI 2 by PDGF-BB was signi®cantly reduced in the presence of endothelium. In cultured vascular endothelial cells, it has recently been demonstrated that NO plays an inhibitory role in bradykinin-or shear stress-induced PGI 2 synthesis (Matthews et al., 1995; Osanai et al., 2000) . Although PDGF-BB does not stimulate the endothelial NO release in the rabbit mesenteric artery, previous studies have demonstrated that large amounts of NO are spontaneously released from the endothelium of the artery (Fujimoto & Itoh, 1997; Li & Kuriyama, 1993) . To con®rm the inhibitory eect of endothelial NO on smooth prostaglandin synthesis, we examined the eects of a NOS inhibitor on the PDGFinduced prostaglandin synthesis in the endothelium-intact arteries. Results showed that the NOS inhibitor completely restored the PGI 2 production in the endothelium-intact arteries, suggesting that the endothelium-derived NO inhibits the PDGF-induced prostaglandin synthesis in smooth muscle.
In summary we have shown for the ®rst time that PDGF-BB causes an endothelium-independent vascular relaxation, which is mediated by the activation of COX-1 and the resulting release of PGI 2 . The PDGF-BB-induced prostaglandin synthesis was found to be dependent on Ca 2+ and tyrosine phosphorylation of the PDGF receptor, and attenuated by endothelium-derived NO.
